Fe(III) distribution varies substantially within and between atherosclerotic plaques

Magnetic Resonance in Medicine

Volumn 71, Issue 2, 2014, Pages 885-892

  Gustafsson, H ^a   Hallbeck, M ^a   Norell, M ^a   Lindgren, M ^b   Engstrom M ^a   Rosen A ^a   Zachrisson, H ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

atherosclerosis; electron paramagnetic resonance; iron; oxidative stress; reactive oxygen species

Indexed keywords

DRUG PRODUCTS; ELECTRON RESONANCE; ELECTRON SPIN RESONANCE SPECTROSCOPY; IRON; IRON METALLOGRAPHY; MACROPHAGES; OXIDATIVE STRESS; PARAMAGNETIC RESONANCE; PARAMAGNETISM; REACTIVE OXYGEN SPECIES; REDOX REACTIONS;

ASYMPTOMATIC PATIENTS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAROTID PLAQUES; ELECTRON PARAMAGNETIC RESONANCE SPECTROSCOPY; IMMUNOHISTOCHEMISTRY; REDOX-ACTIVE IRON;

IRON COMPOUNDS;

IRON; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CLINICAL ARTICLE; ELECTRON SPIN RESONANCE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MIDDLE AGED; OXIDATIVE STRESS; VERY ELDERLY; CAROTID STENOSIS; ECHOGRAPHY; METABOLISM; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION;

AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CAROTID STENOSIS; ELECTRON SPIN RESONANCE SPECTROSCOPY; FEMALE; HUMANS; IRON; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION; ULTRASONOGRAPHY;

EID: 84892444678     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.24687     Document Type: Article

References (40)

1. Virmani R, Burke AP, Farb A, Kolodgie FD,. Pathology of the vulnerable plaque. J Am Coll Cardiol 2006; 47: C13-C18.
2. Libby P,. Inflammation in atherosclerosis. Nature 2002; 420: 868-874.
3. Hansson GK,. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-1695.
4. Finn AV, Nakano M, Narula J, Kolodgie FD, Virmani R,. Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol 2010; 30: 1282-1292.
5. Lendon CL, Davies MJ, Born GVR, Richardson PD,. Atherosclerotic plaque caps are locally weakened when macrophages density is increased. Atherosclerosis 1991; 87: 87-90.
6. Stocker R, Keaney JF, Jr,. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004; 84: 1381-1478.
7. Channon KM,. Oxidative stress and coronary plaque stability. Arterioscler Thromb Vasc Biol 2002; 22: 1751-1752.
8. Madamanchi NR, Vendrov A, Runge MS,. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 2005; 25: 29-38.
9. Drummond GR, Selemidis S, Griendling KK, Sobey CG,. Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat Rev Drug Discov 2011; 10: 453-471.
10. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS,. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 1996; 98: 2572-2579.
11. Barnett HJ, Taylor DW, Eliasziw M, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis: North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1998; 339: 1415-1425.
12. Asymptomatic Carotid Atherosclerosis Study Group. Carotid endarterectomy for patients with asymptomatic internal carotid artery stenosis. JAMA 1995; 273: 1421-28.
13. Halliday A, Harrison M, Hayter E, et al. 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial. Lancet 2010; 376: 1074-1084.
14. Finn AV, Kolodgie FD, Virmani R,. Correlation between carotid intimal/medial thickness and atherosclerosis: a point of view from pathology. Arterioscler Thromb Vasc Biol 2010; 30: 177-181.
15. Sullivan JL,. Iron and the sex difference in heart disease risk. Lancet. 1981; 317: 1293-1294.
16. Stadler N, Lindner RA, Davies MJ,. Direct detection and quantification of transition metal ions in human atherosclerotic plaques: evidence for the presence of elevated levels of iron and copper. Arterioscler. Thromb Vasc Biol 2004; 24: 949-954.
17. Stanley N, Stadler N, Woods AA, Bannon PG, Davies MJ,. Concentrations of iron correlate with the extent of protein, but not lipid, oxidation in advanced human atherosclerotic lesions. Free Radic Biol Med 2006; 40: 1636-1643.
18. Lapenna D, Pierdomenico SD, Ciofani G, Ucchino S, Neri M, Giamberardino MA, Cuccurullo F,. Association of body iron stores with low molecular weight iron and oxidant damage of human atherosclerotic plaques. Free Radic Biol Med 2007; 42: 492-498.
19. Raman SV, Winner MW, III, Tran T, et al. In vivo atherosclerotic plaque characterization using magnetic susceptibility distinguishes symptom-producing plaques. JACC Cardiovasc Imaging 2008; 1: 49-57.
20. Sullivan JL,. Iron in arterial plaque: a modifiable risk factor for atherosclerosis. Biochim Biophys Acta 2009; 1790: 718-723.
21. Formanowicz D,. Do changes in iron metabolism contribute to the acceleration of the atherosclerosis process? J Biotechnol Comput Biol Bionanotechnol 2011; 2: 180-192.
22. Lioupis C, Barbatis C, Drougou A, Koliaraki V, Mamalaki A, Klonaris C, Georgopoulos S, Andrikopoulos V, Bastounis E,. Association of haptoglobin genotype and common cardiovascular risk factors with the amount of iron in atherosclerotic carotid plaques. Atherosclerosis 2011; 216: 131-138.
23. Rajapurkar MM, Shah SV, Lele SS, Hegde UN, Lensing SY, Gohel K, Mukhopadhyay B, Gang S, Eigenbrodt ML,. Association of catalytic iron with cardiovascular disease. Am J Cardiol 2012; 109: 438-442.
24. Wardman P, Candeias LP,. Fenton chemistry: an introduction. Radiat Res 1996; 145: 523-531.
25. Reif DW,. Ferritin as a source of iron for oxidative damage. Free Radic Biol Med 1992; 12: 417-427.
26. Doyle FH, Pennock JM, Banks LM, McDonnell MJ, Bydder GM, Steiner AE, Young IR, Clarke GJ, Pasmore T, Gilderdale DJ,. Nuclear magnetic resonance imaging of the liver: initial experience. Am J Roentgenol 1982; 138: 193-200.
27. Stark DD, Moseley ME, Bacon BR, Moss AA, Goldberg HI, Bass NM, James TL,. Magnetic resonance imaging and spectroscopy of hepatic iron overload. Radiology 1985; 154: 137-142.
28. Anderson LJ,. Assessment of iron overload with T2* magnetic resonance imaging. Prog Cardiovasc Dis 2011; 54: 287-294.
29. Takaya N, Yuan C, Chu B, et al. Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events: a prospective assessment with MRI-initial results. Stroke 2006; 37: 818-823.
30. Hatsukami T, Yuan C,. MRI in the early identification and classification of high-risk atherosclerotic plaques. Imaging Med 2010; 1: 63-75.
31. Crichton R,. Iron metabolism. From molecular mechanisms to clinical consequences. Singapore: John Wiley & Sons Ltd; 2009.
32. Symons MCR, Gutteridge JMC,. Free radicals and iron: chemistry, biology, and medicine. Oxford: Oxford University Press; 2002.
33. Pilbrow JR,. Transition ion electron paramagnetic resonance. Oxford: Oxford University Press; 1990.
34. Jogestrand T, Eiken O, Nowak J,. Relation between the elastic properties and intima-media thickness of the common carotid artery. Clin Physiol Funct Imaging 2003; 23: 134-137.
35. Stoll S, Schweiger A,. EasySpin, a comprehensive software package for spectral simulation and analysis in EPR. J Magn Reson 2006; 178: 42-55.
36. Pelisek J, HEckstein H-H, Zernecke A,. Pathophysiological mechanisms of carotid plaque vulnerability: impact on ischemic stroke. Arch Immunol Ther Exp 2012; 60: 431-442.
37. Michel J-B, Delbosc S, Ho-Tin-Noé B, Leseche G, Nicoletti A, Meilhac O, Martin-Ventura JL,. From intraplaque haemorrhages to plaque vulnerability: biological consequences of intraplaque haemorrhages. J Cardiovasc Med 2012; 13: 628-634.
38. Koole D, Heyligers J, Moll FL, Pasterkamp G,. Intraplaque neovascularization and hemorrhage: markers for cardiovascular risk stratification and therapeutic monitoring. J Cardiovasc Med 2012; 13: 635-639.
39. Alsheikh-Ali AA, Kitsios GD, Balk EM, Lau J, Ip S,. The vulnerable atherosclerotic plaque: scope of the literature. Ann Intern Med 2010; 153: 387-395.
40. Grønholdt M-LM, Nordestgaard BG, Schroeder TV, Vorstrup S, Sillesen H,. Ultrasonic echolucent carotid plaques predict future strokes. Circulation 2001; 104: 68-73.